This page shows the latest pioglitazone news and features for those working in and with pharma, biotech and healthcare.
KIN001 is an orally administered combination of two drugs – pamapimod and pioglitazone – that have demonstrated synergistic antiviral and anti-inflammatory activity, as well as ability to reduce tissue fibrosis, a quality
Since the start of the year, Boehringer Ingelheim has stopped development of its PDE9a inhibitor BI 4093906, Takeda and Zinfandel abandoned efforts to repurpose diabetes drug pioglitazone for the disease, and
Various other treatment approaches have also been tried and failed, including drugs targeting the serotonin pathway as well as diabetes medicine pioglitazone.
Pioglitazone failed to show therapeutic improvements in late-stage testing. A phase III trial of pioglitazone in Alzheimer’s disease has been terminated by Takeda and partner Zinfandel Therapeutics after it ... Pioglitazone was being tested in people
The new guidance allows the drugs to be used first-line for people who cannot tolerate metformin, and in whom sulfonylureas or Takeda's Actos (pioglitazone) are not considered appropriate.
Actos (pioglitazone) is licensed to help patients with type II diabetes reduce their sugar levels and has been on the market for more than 15 years.
More from news
Approximately 5 fully matching, plus 70 partially matching documents found.
Ulcer drug lansoprazole and prostate cancer treatment leuprorelin already faced generic competition and before the deal was completed Takeda's diabetes drug Actos (pioglitazone) lost exclusivity in January 2011.
to its multi-billion dollar main product, the antidiabetic Actos (pioglitazone), in August. ... Takeda's patent on the blockbuster Actos (pioglitazone) for type 2 diabetes expired in January, but an agreement with generic drugmakers Ranbaxy, Watson and
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....